Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN.

Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN. ESC Heart Fail. 2018 08; 5(4):592-602.

View in: PubMed

subject areas

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Biomarkers
Diabetic Nephropathies
Dose-Response Relationship, Drug
Drug Therapy, Combination
Follow-Up Studies
Heart Failure
Humans
Hyperkalemia
Losartan
Potassium
Retrospective Studies
Spironolactone
Stroke Volume
Time Factors
Treatment Outcome

authors with profiles

George Bakris